Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Timothy Fennell, PhD, conducts in vitro and in vivo research investigations funded by industrial, commercial, and government clients. He has more than 30 years of experience in mechanistic-based research and is recognized as an expert in biomarkers, particularly in the area of reactive chemicals/metabolites and exposure assessment via protein- and DNA-adduct measurement. His recent research activities in pharmacology include investigations of the pharmacokinetics of potential therapeutic agents and their ability to cross the blood-brain barrier. Dr. Fennell serves as the director of the RTI Center for Nanotechnology Health Implications Research funded by the National Institute of Environmental Health Sciences. Projects in this Center develop lab-based data for cells and rodents exposed to nanoparticles for the construction and validation of physiologically based pharmacokinetic models to provide a firm basis for the informed assessment of health risks associated with exposure to nanoparticles. He has published more than 100 articles in various national and international scientific journals.
Timothy’s research interests include Biochemistry, Biomarkers, Nanotechnology, Environmental health, Biotechnology and Nanoparticles
Holland NA, Becak DP, Jonathan H Shannahan, Brown JM, Carratt SA, Winkle LSV, Pinkerton KE, Wang CM, Munusamy P, Don R Baer, Sumner SJ, Fennell TR, Lust RM and Wingard CJ*
Research Article: J Nanomedic Nanotechnol 2015, S6-006
Vidanapathirana AK, Thompson LC, Odom J, Holland NA, Sumner SJ, Fennell TR, Brown JM and Wingard CJ
Research Article: J Nanomed Nanotechnol 2014, 5:201